The Inflation Reduction Act, a sweeping bill led through Congress by Democrats in 2022, included a provision to allow the government to negotiate prices for Medicare drugs. This week, news came out that the program will save $6 billion between the government and individual co-pays in its first year, 2026. That's the case with ten drugs in 2026, but the list will expand from there.